Clinical Trial Protocol
Protocol ID: CTL-2025-001 | Version 1.0 | 23-Jun-2025
SYNOPSIS
• Study Phase: Phase IIb
• Target sample size: 120 participants
• Study duration: 12 months
• Number of clinic visits: 8
OBJECTIVES
Primary: Evaluate efficacy of Drug X versus placebo.
METHODS
Approximately 100 subjects will be randomized (in a 1:1 ratio) to receive Drug X or placebo.
The study will last 14 months in total.
The schedule of assessments outlines 10 on-site visits.
INCLUSION CRITERIA
1. Adults aged 18–65
2. Diagnosis of Condition Y
EXCLUSION CRITERIA
1. Pregnant or breastfeeding
2. Severe renal impairment